MHP
APYX icon

Manatuck Hill Partners’s Apyx Medical APYX Stock Holding History

Manatuck Hill Partners’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-125,000
Closed -$449K – 90
2016
Q4 		$449K Buy
+125,000
New +$557K 0.22% 63

Other funds holding APYX

GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Manatuck Hill Partners's APYX Position: Q1 2017 in Review

Manatuck Hill Partners sold out of Apyx Medical (APYX) in Q1 2017, closing a stake of 125,000 shares — an estimated $449K sold.

Manatuck Hill Partners first reported a position in APYX in Q4 2016 and held it in 1 quarter. The position peaked at $449K in Q4 2016. 37 funds tracked by Wall St. Rank hold APYX as of Q1 2017.

  • Manatuck Hill Partners reported no remaining Apyx Medical position as of Q1 2017 after selling out during the quarter.
  • Manatuck Hill Partners sold 125,000 Apyx Medical shares in Q1 2017, an estimated $449K.
  • Manatuck Hill Partners first reported a position in Apyx Medical in Q4 2016 and held it in 1 quarter.
  • Manatuck Hill Partners's Apyx Medical position peaked at $449K in Q4 2016.
  • 37 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2017.

Based on Manatuck Hill Partners's 13F filing for Q1 2017, filed 15 May 2017.